These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 1893319)
21. [Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program]. Abarca V K; Cerda L J; Ferreccio R C Rev Med Chil; 2009 Jan; 137(1):10-7. PubMed ID: 19399316 [TBL] [Abstract][Full Text] [Related]
22. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults]. Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155 [TBL] [Abstract][Full Text] [Related]
23. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
24. Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Blumberg DA; Lewis K; Mink CM; Christenson PD; Chatfield P; Cherry JD Pediatrics; 1993 Jun; 91(6):1158-65. PubMed ID: 8502521 [TBL] [Abstract][Full Text] [Related]
25. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK; Siber GR Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [TBL] [Abstract][Full Text] [Related]
26. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination. Jackson LA; Starkovich P; Dunstan M; Yu O; Nelson J; Dunn J; Rees T; Zavitkovsky A; Maus D; Froeschle JE; Decker M Pediatrics; 2008 Mar; 121(3):e646-52. PubMed ID: 18310184 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Chan SH; Tan PT; Han HH; Bock HL Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239 [TBL] [Abstract][Full Text] [Related]
28. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. Sato H; Sato Y Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030 [TBL] [Abstract][Full Text] [Related]
29. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
30. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Ipp MM; Gold R; Goldbach M; Maresky DC; Saunders N; Greenberg S; Davy T Pediatrics; 1989 May; 83(5):679-82. PubMed ID: 2717284 [TBL] [Abstract][Full Text] [Related]
31. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of a new combined inactivated DPT-polio vaccine. Drucker J; Soula G; Diallo O; Fabre P Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861 [TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents. Huang LM; Chang LY; Tang H; Bock HL; Lu CY; Huang FY; Lin TY; Lee CY J Adolesc Health; 2005 Dec; 37(6):517. PubMed ID: 16310132 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. Khetsuriani N; Music S; Deforest A; Sutter RW J Infect Dis; 2000 Feb; 181 Suppl 1():S208-12. PubMed ID: 10657216 [TBL] [Abstract][Full Text] [Related]
35. Neutralizing antibodies in 6-year-old children after five doses of tetanus toxoid. Pérez-Trallero E; Cilla G; Urbieta M; Dorronsoro M; Saenz-Dominguez JR Vaccine; 1993; 11(6):619-20. PubMed ID: 8322483 [TBL] [Abstract][Full Text] [Related]
36. [Study on the immunity of diphtheria in children at county level with different 4-vaccine coverage rates based on the results from "National Immunization Program Review" in 2004]. Wang HQ; Guo X; Chen LJ; Yang J; He JG; Luo M; He X; Zhou YQ; Cao LS; Lu Y; Yin DP; Chen YS; Xia W; Liang XF Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):433-6. PubMed ID: 17877168 [TBL] [Abstract][Full Text] [Related]
37. Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test. Sonobe MH; Trezena AG; Guilhen FB; Takano VL; Fratelli F; Sakauchi D; Morais JF; Prado SM; Higashi HG Braz J Med Biol Res; 2007 Jan; 40(1):69-76. PubMed ID: 17224998 [TBL] [Abstract][Full Text] [Related]
38. Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Simonsen O; Klaerke M; Klaerke A; Bloch AV; Hansen BR; Hald N; Hau C; Heron I Acta Pathol Microbiol Immunol Scand C; 1986 Oct; 94(5):219-25. PubMed ID: 3565028 [TBL] [Abstract][Full Text] [Related]
39. [Booster vaccination with a diphtheria-tetanus vaccine for dermo-jet with low diphtheria toxoid content]. Wegmann A; Heiz R; Baumann T Schweiz Med Wochenschr; 1976 Jan; 106(4):112-4. PubMed ID: 1251161 [TBL] [Abstract][Full Text] [Related]
40. International collaborative studies on potency assays of diphtheria and tetanus toxoids. Van Ramshorst JD; Sundaresan TK; Outschoorn AS Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]